date:Aug 06, 2012
s breeding mutant O104 strains genetically designed to fail at biofilm production.
Once in O104-infected humans, these mutant strains could reproduce in a way that genetically 'knocks out' O104's ability to produce the biofilm.
But even then, Manning said, researchers will need to consider how to deliver such a treatment to a population:
Even if you do find the magical treatment, how do we figure out who to treat? she asked. Would we give it to people who are at risk? People who are already i